Information
-
Trademark
-
88476971
-
International Classifications
-
Filing Date
June 17, 2019
5 years ago
-
Transaction Date
April 12, 2021
3 years ago
-
Status Date
April 11, 2021
3 years ago
-
Location Date
April 11, 2021
3 years ago
-
Status Code
602
-
Current Location
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
Employee Name
MESSICK, TABITHA LEE
-
Attorney Docket Number
54163-TM1002
Attorney Name
Aaron D. Hendelman
Law Office Assigned Location Code
L40
-
Owners
Mark Drawing Code
4000
Mark Identification
T-LITE
Case File Statements
- GS0421: Medical and pharmaceutical research services; pharmaceutical research and development; pharmaceutical research and development related to the prevention or treatment of disease with substances that stimulate the immune response; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the field of immunotherapy; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases
- PM0001: T LIGHT
Case File Event Statements
-
4/12/2021 - 3 years ago
17 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
4/11/2021 - 3 years ago
16 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
9/28/2020 - 4 years ago
15 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/28/2020 - 4 years ago
14 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/28/2020 - 4 years ago
13 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/10/2020 - 4 years ago
12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
3/10/2020 - 4 years ago
11 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
3/10/2020 - 4 years ago
10 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
3/7/2020 - 4 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/6/2020 - 4 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/6/2020 - 4 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/9/2019 - 5 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/9/2019 - 5 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/9/2019 - 5 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
9/8/2019 - 5 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/27/2019 - 5 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
6/20/2019 - 5 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP